Related Experiment Video
Updated: Jan 4, 2026

11:28
Recording Network Activity in Spinal Nociceptive Circuits Using Microelectrode Arrays
Published on: February 9, 2022
3.3K
[Neurotoxicity in long-term lithium therapy: an electroneurographic study]
A Eisenstädter1, A Seiser, M Brainin
1Neurologische Abteilung, NO Landeskrankenhaus Klosterneuburg.
Wiener Klinische Wochenschrift
|March 3, 1989
Summary
Long-term lithium therapy in 16 patients revealed pathological changes in peripheral nerve conduction, correlating with treatment duration. These findings suggest a potential chronic neurotoxic effect of lithium on nerves, even without clinical symptoms.
Area of Science:
- Neurology
- Toxicology
- Neuroscience
Context:
- Lithium is a widely prescribed mood stabilizer for bipolar disorder.
- Long-term lithium use can have various side effects, but peripheral nerve effects are not well-established.
- This study investigates subclinical peripheral nerve changes in patients on chronic lithium therapy.
Purpose:
- To assess peripheral nerve function in patients undergoing long-term lithium treatment.
- To determine if there is a correlation between the duration of lithium therapy and nerve conduction abnormalities.
- To explore the potential neurotoxic mechanisms underlying these changes.
Summary:
- Pathological changes in peripheral nerve conduction were observed in 16 patients on long-term lithium therapy (mean duration 8.3 years).
- These nerve conduction abnormalities correlated significantly with the duration of lithium treatment.
- No patients exhibited clinical signs of polyneuropathy or other associated conditions, indicating subclinical changes.
Impact:
- This research highlights a potential chronic neurotoxic effect of lithium on peripheral nerves.
- It suggests the need for monitoring peripheral nerve function in patients on long-term lithium therapy.
- Findings may inform clinical practice regarding lithium's long-term safety profile.
Related Concept Videos
Long-term Potentiation
58.0K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
58.0K
Long-term Potentiation
3.3K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
3.3K
Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
Long-term Depression
32.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.9K
Electroconvulsive Therapy
729
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
729

